Exchange: NASDAQ
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 4/5/2013
Last 10 Quotes:
What's This?
Earnings vs. Expectations
Compare| Mar 2012* | Jun 2012* | Sep 2012* | Dec 2012* | Mar 2013* | |
| * Quarter Ending | |||||
|---|---|---|---|---|---|
| Estimated EPS($) | 1.13 | 1.19 | 1.26 | 1.32 | 1.35 |
| Reported EPS($) | 1.08 | 1.22 | 1.29 | 1.32 | NA |
| GAAP($) | 0.90 | 0.82 | 0.97 | 0.61 | NA |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
| Average Estimate ($) | 1.35 | 1.42 | 5.69 | 6.84 |
| Number of Analysts | 29 | 28 | 30 | 30 |
| Low Estimate ($) | 1.25 | 1.37 | 5.55 | 6.17 |
| High Estimate ($) | 1.46 | 1.55 | 6.02 | 7.61 |
| Mar 2013* | Jun 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
|---|---|---|---|---|
| Current Estimate ($) | 1.35 | 1.42 | 5.69 | 6.84 |
| 30 Days Ago ($) | 1.35 | 1.42 | 5.66 | 6.82 |
| 90 Days Ago ($) | 1.36 | 1.39 | 5.58 | 6.64 |
| Dec 2013* | Dec 2014* | Next 3 Years (per year) | Forward P/E | PEG | ||
| * Year Ending | ||||||
|---|---|---|---|---|---|---|
| CELG | 29.29% | 16.07% | 21.22% | 20.59 | 0.83 | |
